Table 3.
Ref.
|
Outcome considered
|
Results
|
Khateri et al[108] | Incidence of acute liver injury in patients affected by COVID-19 | Acute liver injury has no relationship with age |
Metawea et al[110] | Mortality of patients with hepatocellular carcinoma infected with COVID-19 | Age is associated with poorer outcomes and higher mortality |
Ji et al[111] | Severe COVID-19 in patients affected by NAFLD | Associated in patients older than 60 yr |
Zhou et al[112] | Severe COVID-19 in patients affected by NAFLD | Associated in patients younger than 60 yr |
Hartl et al[113] | Liver-related death due to COVID-19 between different age groups | More frequent in the 40-69 years old group than in the over 70 years old group (6.5% vs 2.2%) |
Ioannou et al[115] | Predictors of mortality among patients with cirrhosis and SARS-CoV-2 infection | Advanced age was one of the main risk factors for mortality among patients with cirrhosis and SARS-CoV-2 infection |
Brozat et al[116] | The case fatality rate in patients with cirrhosis and SARS-CoV-2 infection | The case fatality rate in cirrhotic patients and SARS-CoV-2 infection aged 65 yr and older was nearly three times that in patients younger than 65 yr (43.6% vs 16.1%) |
SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2; COVID-19: Coronavirus disease 2019; NAFLD: Non-alcoholic fatty liver disease.